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Abstract
This paper explores the perspectives of women who have agreed that their umbilical cord blood may be
collected for a public ‘cord blood bank’, for use in transplant medicine or research. Drawing on interview
data from 27 mothers who agreed to the collection and use of their umbilical cord blood, these choices
and the informed consent process are explored. It is shown that the needs of sick children requiring
transplants are prominent in narrative accounts of cord blood banking, together with high expectations
for future applications of stem cells. Given this dynamic, a concern arises that the complex and multiple
uses of tissues and related data might be oversimpliﬁed in the consent process. In conclusion, the positive
ﬁnding of a commitment to mutuality in cord blood banking among these women is underlined, and its
implications for the wider debate on cord blood banking are discussed.
Background: cord blood stem
cell banking
Stem cells isolated from blood or bone marrow are known
as haematopoietic stem cells. Stem cells from umbilical
cord were ﬁrst used in transplant medicine in 1988.
1
Over the next two decades, a scientiﬁc consensus was
slowly forged that the use of cells from cord blood was
an effective alternative to cells from bone marrow in treat-
ments for some malignant and metabolic diseases.
2
The great majority of cord blood transplants carried
out have been of cells from unrelated donors, with a
process of tissue typing taking place to ‘match’ donor and
recipient cells as closely as possible. This avoids some of
the pressures and ethical dilemma associated with using
cells from related donors. Following processing and
testing, these cells are stored at extremely low tempera-
tures, until they are identiﬁed as a good or sufﬁcient
match for a patient in need of a transplant. Hence, they
can be stored for future use in the treatment of patients
with malignant or other serious diseases. National and
international registries hold data about these cells, in
order that searches can take place for patients as the
need arises. A major clinical advantage of using the cells
already collected from umbilical cord blood is that it is
relatively quick to obtain the cells once a patient needs
them.
3 This contrasts with the situation for bone marrow
donors, in which a period of several months typically
elapses while a potentially suitable volunteer is contacted
and it is conﬁrmed that they are willing and able to donate.
A useful distinction can be made between the private
cord banks that operate in the commercial sector and the
public cord banks that are supported by public funds.
Taking a population approach to health need, public
cord banks aim to maximize successful matches for trans-
plants for patients with acute leukaemia and other severe
diseases. In contrast, commercial organizations offer a
service on demand to parents who can and wish to pay
for it generally for their own family’s exclusive use.
These private cord banks often promote speculation that
novel cell therapies might be developed that utilize the
patients’ own pre-deposited cells. Their activities have
proved controversial, not least because they promote and
could proﬁt from unrealistic expectations about future
regenerative therapies. There have also been concerns
expressed about possible risks to the mother of the
process of cord blood collection. However, there is a lack
of clear evidence about this.
4 Professionals involved in
cord blood collection for public facilities argue that with
good practice, donors will not be put at risk.
5 The regulat-
ory stance taken towards such enterprises varies greatly
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cists and politicians who have objected to private cord
blood banking emphasize that solidarity should be the key
principle in tissue banking, as has long been the consensus
in Europe.
6 Private and consumer activity in this respect is
seen as rupturing that consensus. While the depth and
importanceofthiscontroversyisclear,ithasarguablydomi-
nated discussion to the extent that a wider exploration
about cord blood banking and public policy has yet to
take place. This might include a consideration of parents’
involvement in the now extensive public cord blood bank
sector. It is to this wider discussion that this paper is
addressed.
What do we know about mothers’
views on the collection of cord blood
for public cord blood banks?
Very little is known about the perspectives of mothers
agreeing to the collection of umbilical cord blood for
public cord banks, whether for medicine or for research.
Scientiﬁc publications predominantly refer to ‘cord blood
donors’ only insofar as the variables they present may
pertain to the biological quality of cord blood. The ques-
tion of the views of fathers is largely absent, as are the
views of ‘donor children’. (The tentative use of terminol-
ogy here reﬂects some ﬂuidity about claims to ‘ownership’
of this biological material: although it is usual practice in
the UK to treat this biological material as belonging to
the mother, there is also a claim that it ‘belongs’ to the
child. Depending on which view is accepted, the mother
would be consenting to donate, or agreeing to the collec-
tion of the child’s cord blood.
7) Among the few studies
published about donors’ views is Danzer et al.’s study
8
with women who had donated cord blood. Based on ques-
tionnaire data, this is the only publication found in a
recently conducted literature review that explored
women’s views after rather than before the birth. The
great majority of Danzer et al.’s respondents reported that
they would donate again. However, they also ‘indicated
having anxiety or objections regarding genetic testing
and about the possibility of improper use of donated
(umbilical cord blood)’.
8 Fernandez et al.
9 conducted a
survey of knowledge and attitudes about cord banking
among women attending an antenatal clinic in Halifax,
Canada. A high proportion of those questioned supported
the idea of public cord banking. However, some wanted
more information on cord banking and about a quarter
indicated that the cord blood bank should not be used to
investigate the health of the newborn. It appears from
these studies that some of the practices that are considered
usual and necessary by cord banks are viewed with some
ambivalence by those women whose views have been
sought.
Moving to the question of knowledge and expectations
surrounding cord blood banking, Fox et al.
10 conducted a
survey of pregnant patients in a New York antenatal facil-
ity. They point to knowledge of cord blood therapies being
‘strikingly poor’, and to expectations being very high.
Speciﬁcally, the great majority of patients in Fox et al.’s
study believed that cord blood cells have already been
used successfully to treat Alzheimer’s disease, Parkinson’s
disease and spinal injury, which is not the case. These
recent ﬁndings about the beliefs of pregnant women
attending a New York clinic may be illuminated by socio-
logical work on the dynamics of expectations in stem cell
medicine.
11 For sociologist Catherine Waldby, the empha-
sis has been on private cord banking, which she describes
as offering ‘a form of popular participation in the open-
ended promise of commercial biotechnology’.
12 However,
the view taken in this paper will be that expectations in
the possibilities and futures represented by stem cell
science may be considered a broader phenomenon, as we
can discern in the report of the ﬁndings from a large-scale
‘stem cell dialogue’ recently conducted in the the UK.
13
Thus sociological work on expectations may be relevant
to the scientiﬁc ﬁeld more broadly, including activities
in the public sector. This paper will draw upon these socio-
logical perspectives in thinking about women’s involve-
ment in cord blood donation, as well as on the limited
literature on consent referred to above.
As we have seen, little is known about how cord blood
donation might be experienced, how the consent process is
negotiated, and what it might mean to those involved.
Taking inspiration from discussions on empirical bioethics,
14
and from qualitative research on the process of informed
consent,
15 this paper begins to explore these questions.
Interviews with women consenting
to cord blood collection and ‘banking’
for future public and research use
This paper draws on an empirical case study of a new
public cord blood bank in England that is being developed
by an established bone marrow donor charity in
collaboration with the National Health Service (NHS).
The initiative aims to expand the collection and supply
of cord stem cells for medical treatment and research,
which is already conducted on a limited scale by the
NHS National Blood Service. As the likelihood of
ﬁnding a matched bone marrow donor is lower for
non-Caucasian patients than for Caucasians, the new
initiative – like most public cord blood banks – has a
particular focus on collecting large numbers of donations
from an ethnically diverse population. A major aim of
the new collection programme is to give thorough infor-
mation to prospective mothers on the uses and potential
beneﬁts of cord blood banking, and to obtain their
consent to collect the cells for the public bank.
16
The author, who is conducting a larger project about
multiple perspectives on the ethics of cord blood
banking, approached the team to request access to inter-
view women taking part in the new collection programme.
Following an extensive discussion of the operational and
ethical implications, access was agreed. Once agreed,
established conventions for recruitment of interviews
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from participants to ‘opt in’ to interviews if they wished
to do so by authorizing that their contact details be
passed on. The author did not observe any clinical consul-
tations but did observe four of the midwife’s presentations
to groups of parents who were visiting the hospital.
Given the pressures on women during the antenatal
period and when attending the hospital, it was decided
that speaking with them after the birth was the most
appropriate way of conducting these interviews. Forty-ﬁve
women who were due to give birth at the collaborating
NHS maternity hospital over a period of six months
consented to the collection of cord blood for the pilot
stage of the new programme. This entailed giving their
agreement that blood from the umbilical cord could be
collected by a midwife with specialist training, who was
not part of the team providing clinical care to the
mother and baby, if she felt it was appropriate to do so
at the time of their delivery. Of these women, 36 also
‘opted in’ to be contacted at a later date about a research
interview.
The thirty-six women recruited in this way were con-
tacted for interview at six–eight weeks after their child-
birth, regardless of whether the donation was eventually
able to go ahead. In three cases, the collection of cord
blood had not proceeded due to either a lack of available
personnel or clinical considerations at the time of delivery.
Twenty-seven interviews were undertaken with women
who had consented to cord blood collection, and in ﬁve
cases husbands or partners were also able to take part in
the interviews. The remainder either had moved away
from the area (3), could not be contacted (4) or did not
wish to take part in the interviews (2). Reasons cited for
not taking part in the interviews were pragmatic (lack of
time), or a feeling that, as the cord blood could not be col-
lected, there was little to say in an interview about this
project. Because this is a small group of patients who
might be identiﬁable from details such as their ethnicity
and occupations, these details are not provided for individ-
uals, to whom anonymity was promised. It was agreed by an
NHS ethics committee that these interviews could be
undertaken. Women registered as ‘cord blood donors’
who had agreed to be contacted were phoned 6–8 weeks
after the birth of their babies to ask if they would be
willing to be interviewed. Arrangements were then made
if they wished to go ahead. The interviews were conducted
at the interviewees’ own homes, with the exception of one
conducted by phone and one at the hospital. All inter-
views were recorded, with consent, and transcribed. Most
of those interviewed had just had their ﬁrst baby, and
the majority held professional jobs, to which they intended
to return. The predominant ethnicity of this group accord-
ing to their own deﬁnitions was ‘White British’, but the
sample also included women from European and Black
Afro-Caribbean groups.
A topic guide for these interviews included questions
designed to illuminate the knowledge, expectations, con-
cerns and experiences of these women in relation to cord
blood banking. The analysis focused on these areas and
in particular on an exploration of the ethical and practical
rationales presented for donating to the public cord bank.
A data matrix was used to summarize key aspects and
themes from the data. Techniques from ‘grounded theory’
approaches were used to open up an exploration of what
consent means in this context.
17
The recruitment process for women
agreeing to collection of cord blood
Following the implementation of the Human Tissue Act
(2004), the obtaining of consent is a formal requirement
for the collection or ‘procurement’ of human tissues in
England, Wales and Northern Ireland.
18 This consolidates
a shift from a regulatory approach in which tissues
obtained in clinical contexts were sometimes regarded as
‘abandoned’, to one in which consent from the patient is
seen as central. This qualitative research focused on
exploring donors’ narratives, rather than scrutinizing the
effectiveness of information-giving or compliance with
formal consent processes. However, it was hoped that
exploring and describing the women’s experiences would
be informative for the cord bank team as they reviewed
their practices and moved forward with their project.
The primary means for providing information to
potential donors were information leaﬂets made available
at various points in the hospital’s maternity services, and
presentations on the project after the regular ‘labour
ward tour’, which women may attend towards the later
stages of their pregnancy, often accompanied by their part-
ners. The information leaﬂet provides basic information
about the process of collection and of consenting or
‘opting in’ to participation in the project. Written infor-
mation speciﬁes that consent is to collection of cord
blood and blood samples, testing of cord blood and
samples, use of relevant medical data from the maternity
unit, the possibility of clinical feedback from testing in
some cases, use of cord blood for a public cord bank, in
the cell therapy laboratory, and in ethically approved
research. It is stated that cord blood only meets the
threshold quality standards currently used in transplant
medicine in less than half the cases where collection
takes place. The possibility of the remaining cord blood
being used for research is therefore also explicitly referred
to in the introductory leaﬂet.
During her presentation, the midwife coordinator
gives a layered and historical account of the rationale for
the collection of cord blood cells. The presentation takes
the form of an account of the setting up of national and
international bone marrow registers, and of the emergence
of umbilical cord as an alternative source of stem cells for
transplants. An indication is given of the range of diseases
that are, sometimes, treated with these cells. The recipi-
ents of transplants, often children with acute leukaemias
or severe blood disorders, have a central place in this nar-
rative, and those who died waiting for a transplant are also
referred to. The project’s cell bank and research laboratory,
and their aims, are described in terms of increasing the
24 Busby
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developing future treatments. Thus the project that is pre-
sented crosses the scientiﬁc divide between conventional
transplant medicine/haematology and regenerative thera-
pies, and encompasses both these possible futures. A pro-
missory dynamic is evident here, but one that is different
from the individualized one that has been described in
relation to private cord blood banks.
19 The narrative that
emerges is a powerful one that merges together the
missing futures for the children who did not reach adult-
hood, the futures regained for children who were recipients
of successful transplants and the future needs of unknown
children and adults. The promise that is being constructed
refers both to established transplant treatments that are life
saving for some children with severe diseases, and to pos-
sibilities of new regenerative therapies in the future.
While the project information refers to the possibility of
cord blood being used in research, the headlines of
patient leaﬂets, press releases and the midwife’s presen-
tation all refer to the double ‘gift of life’ of a newborn
who might save the life of a sick child. This is echoed in
the following phrase on the cover of the information
leaﬂet for women invited to donate: ‘Your Birth Day
gift...Helping to save a life’.
The collection procedure is also explained by the
midwife coordinator, who conveys with conviction the
commitment that collection would only take place if she
was assured that it would in no way compromise the care
of mother and baby. The potential for transformation
from donated cells is contrasted with the usual alternative
to donation (in this and many hospitals), which is disposal
of tissues that are designated as clinical waste. The mother
also agrees to donate blood samples for testing, and for any
tests to be carried out on the blood sample or the cord
blood itself that may be in the interests of recipients.
She must consent to being contacted if any ‘positive
results’ are found that may have implications for her or
her baby’s health – and is advised that she may not take
part if she does not wish to be contacted about these.
Thus she is agreeing to the use of her own and her
child’s biological material and related data in a number
of ways, and over an unspeciﬁed period of time. Finally,
the mother agrees to re-contact at six months for a
second blood test and a health questionnaire.
Consent and the framing
of possibilities
All of the women interviewed said that they had discussed
the cord blood collection with the midwife coordinator
and had been given written information before giving
their consent, thus meeting the formal ethical require-
ments for a project of this kind. Some had not heard of
the possibility of cord blood banking before:
‘I’d never even heard of cord blood banking. To me it was
just something, I just assumed that like the placenta, it was
just thrown away straight after the birth.’ (Interview 23)
While a few of the early donors were members of the hos-
pital professional community, the majority had become
involved with the project on the basis of seeing the
project leaﬂet or hearing about the project during their
labour ward tour. Still, they were aware of the hospital’s
status as a teaching hospital with high levels of research
activity, and especially of its high reputation in the ﬁelds
of midwifery and obstetrics. It was evident that many of
these donors approached the invitation to participate in
this light. Consenting to the cord blood collection, then,
was bound into the relationships with staff at the maternity
unit services. However, most viewed the cord blood
donation process as ‘straightforward’, in that no additional
appointments or major interventions were required:
‘It didn’t involve a lot from us, because it was something that
was valuable for...valuable for us in terms of, you know, we
got to feel like we were doing something useful and helpful
and the possibly that maybe if we needed it [in] the future we
might be able to access it. And ...something that would go
to waste would be helpful for other people.’ (Interview 24)
The suggestion that waste disposal would be the alterna-
tive destiny for umbilical cord, voiced in these two short
extracts, was a common one. The posing of these stark
contrasts between waste disposal and biological potential
is part of the compelling nature of these narratives. This
discourse has some similarities with language sometimes
used about the sourcing of tissues and cells from women
attending in vitro fertilization and abortion clinics.
20,21
Yet while researchers working in those contexts found
ambivalence and contest around these assumptions
among donors, here the idea of cord blood as clinical
waste seemed to be shared to a great extent by these
mothers and their midwives.
Participants in the cord blood bank have to hold in
the balance the possibilities of ‘saving a life’ for a patient
who needs a transplant, and of the cells being used in
the laboratory. Their particular sample might be used to
test a laboratory process or, perhaps, the cells derived
from it might be used eventually in the development or
testing of new cell therapies. Mothers, and partners
when present at the interviews, were asked about any con-
cerns they might have regarding the use of the cord blood.
Some did comment on risks that arise when tissues are
used for research, and when personal data are kept in
this context. A few indicated that they were aware of
stories or scandals about blood or organs being sold. One
partner expressed his concerns about the possibility that
animals might be used in research related to cord blood
stem cells in the future – but stated that he had not
wished to take up too much time discussing these problems
or raising controversial issues at the midwife’s presentation.
This hints at the ways in which ‘etiquette’ in a clinical
context might militate against a robust discussion of
research with people who are part of a clinical team
caring for one’s family. Notwithstanding these doubts,
they (all) indicated, however, that they had made a
decision to entrust the project with the responsible use
of the cord blood cells:
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hope it will do all the good.
HB: So, if they do research to understand more about the
cells?
Whatever it takes, just take you forward. So I’m ﬁne with
that.’ (Interview 18)
There is a sense that the hopeful and optimistic stance
often taken in the course of these interviews may deﬂect
participants from dwelling on the possibility of subsequent
use of information in this context: as explained above,
mothers are informed by the cord bank of the possibility
of feedback of information that might be clinically rele-
vant for them, or their children. In addition, it is likely
that new tests will in future be introduced for donated
cells to minimize the risks of using them in patients/reci-
pients. This dimension does not yet appear to have been
sufﬁciently considered. One outcome of this research
therefore was a recommendation to the cord blood bank
that the arrangements for feedback to mothers from clini-
cally relevant tests be clariﬁed, and that the implications of
such tests for donors be kept under review. The phenom-
enon of tension between donors’ and recipients’ interests
in relation to screening of donated tissues is by no means
exceptional. However, it has emerged in these interviews
that there is potential for the intense needs of recipients
to overshadow interests of donors in discussions about
donation for transplant medicine and stem cell research.
Discussion: the multiple meanings of
consent to the donation of umbilical
cord blood
This paper has drawn on a small set of exploratory inter-
views conducted as part of a larger study about multiple
perspectives on cord blood banking, and no claims are
made for generalizability of these ﬁndings. A positive
feature of the approach taken here is that women were
interviewed after the birth, but sufﬁciently close to the
time of donation for a detailed discussion to be held
about their involvement with the cord blood bank. This
is in contrast to the few published studies of women’s
views on cord blood banking, which have mostly been
undertaken before the birth. However, it is clear that the
practicalities of caring for a baby of a few months old
may also constrain the possibility of fuller consideration
of the implications of donating. Different accounts might
emerge if donor mothers were re-interviewed. In addition,
the perspectives of children might be considered using
methods such as those deployed in the Avon
Longitudinal study of parents and children.
22 A longitudi-
nal approach to researching the perspectives and interests
of mothers and children would be informative as public
cord blood projects of this kind become established in
the longer term.
Drawing on interviews with mothers, it has been
emphasized that consent in this case is only partially
‘informed’: this is in part because, as in other emerging
ﬁelds of science where basic and translational research is
unfolding, it is not possible for researchers to state in
detail what research will be undertaken. Women are
invited to agree to authorize the collection of the cord
blood, and to agree that the cord bank will in effect be
the custodian of the donation for good in the future.
The invitation to consider donating cord blood cells thus
calls them and their partners into an uncertain future.
This uncertainty extends to the use of data from the
donated material. The ambiguity about the uses of infor-
mation in this context – that may for example arise
from the testing of the cord blood for the beneﬁt of the
recipient – is an important ethical issue for public cord
blood banks to address in the future. This relates particu-
larly to the possible implications of such data for ‘donor’
children, who are implicated but too young at this time
to be asked about their views.
In this paper, the informed consent process is also seen
as a space in which midwives and parents develop narra-
tives about the possibilities associated with the use of
cord blood. As with traditional blood services, the initiat-
ive builds on the understanding that everyone is poten-
tially dependent on transplant medicine, so that any
child or adult may need help from a public cord blood
bank. Donors to the cord blood bank also approached
this with great interest in the future possibilities of regen-
erative medicine. In conclusion, while much of the public
debate about cord blood banking has focused on the prob-
lems associated with the private storage of cord blood stem
cells, this study suggests that parents may also be pro-
foundly interested in the future provision of stem cell
banking within an ethic of mutuality. Further and larger
scale work will be needed to explore the extent, limits
and implications of this support for public cord blood
banking.
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